Breast biomechanics research highlights systemic gaps in women's health science and corporate product design
Original framing: “Job titles of the future: Breast biomechanic” — MIT Technology Review
The original framing omits the historical marginalization of women in medical research, the role of corporate influence in shaping health product development, and the lack of indigenous or cross-cultural perspectives on breast health. It also fails to address how systemic sexism in STEM fields has delayed progress in this area.
Low structural omission detected in mainstream coverage.
This narrative is produced by MIT Technology Review, a publication that often frames technological advancements as neutral progress, obscuring the power dynamics of who controls research funding and product design. The framing serves corporate interests by positioning breast biomechanics as a futuristic innovation rather than addressing the historical underinvestment in women's health. It also obscures the role of patriarchal structures in devaluing female-specific research.
The neglect of breast biomechanics reflects a long history of women's health being sidelined in medical research, from the exclusion of women in clinical trials to the lack of funding for female-specific conditions. Historical parallels can be drawn to the slow recognition of conditions like endometriosis, which were long dismissed as psychological rather than physiological.
The emergence of breast biomechanics as a specialized field is not just a story of technological progress but a symptom of systemic neglect in women's health research.